Navigation Links
NeoStem Chairman and CEO to be Honored at the Moves 2010 Power Women Awards

NEW YORK, Nov. 9, 2010 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that NeoStem's Chairman and CEO, Dr. Robin L. Smith, M.D., MBA, will be honored tonight at Moves Magazine's 2010 Power Women Awards Dinner & Ceremony beginning at 6:30 pm at the Astor Center, 399 Lafayette Street, New York City.

This event marks the seventh year of the Moves Power Women Awards. The event will be hosted by Kerry Washington, an actor and member of the President's Committee on the Arts and Humanities. According to Moves Magazine, the 2010 Power Women Awards honors "successful and influential women of substance… power women."

Robin Smith commented, "I am honored to be among such fabulous women. As an entrepreneur, philanthropist, and physician, my life is centered around others and my greatest reach will be through my work at NeoStem, where we focus on adult stem cells and search for ways to repair damaged tissues and find treatments and cures for many debilitating diseases and conditions. We also enable healthy adults to have their stem cells stored should they be needed in the future as a Bio-insurance."

About NeoStem, Inc.NeoStem, Inc. is engaged in the development of stem cell-based therapies, pursuit of anti-aging initiatives and building of a network of adult stem cell collection centers in the U.S. and China that are focused on enabling people to donate and store their own (autologous) stem cells for their personal use in times of future medical need. The Company is also the licensee of various stem cell technologies, including a worldwide exclusive license to VSEL™ Technology which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. NeoStem's majority-controlled Chinese pharmaceutical operation, Suzhou Erye, manufactures and distributes generic antibiotics in China. For more information, please visit:

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include the future of VSEL™ Technology and adult stem cells as a viable treatment option, about which no assurances can be given. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as other periodic filings made with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.For more information, please contactNeoStem, Inc.Robin SmithPhone: +1 (212) 584-4174E-mail: rsmith@neostem.com

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy
2. FOX Business Network Airing In-Depth Look at NeoStem
3. NeoStem to Present at Rodman & Renshaws 12th Annual Healthcare Conference
4. NeoStem Provides Second Quarter Update
5. NeoStem to Receive $700,000 from the U.S. Armys Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds
6. NeoStem Named Best Stem Cell Company in The New Economys 2010 Biotech Awards
7. NeoStem Achieves New Milestone as Company Joins Russell 3000 Index
8. NeoStem Raises $5 Million in Registered Direct Offering
9. NeoStem Selected to Present at American Society for Apheresis
10. NeoStems Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference
11. NeoStem to Ring Opening Bell at New York Stock Exchange on May 27, 2010
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, ... of the Supplyframe Design Lab . Located in Pasadena, Calif., the Design ... of how hardware projects are designed, built and brought to market. , The ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
Breaking Biology News(10 mins):